Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity
and mortality. There have been many advances in the field of PE in the last few years …

There is a growing clinical and scientific interest in catheter-directed therapy (CDT) of acute
pulmonary embolism (PE). Currently, CDT should be considered for patients with high-risk …

Pulmonary embolism (PE) represents the third leading cause of cardiovascular mortality.
The technological landscape for management of acute intermediate-and high-risk PE is …

Treatment strategies for complex patients with pulmonary embolism (PE) are often debated
given patient heterogeneity, multitude of available treatment modalities, and lack of …

The coexistence of coronavirus disease 2019 (COVID-19) and pulmonary embolism (PE),
two life-threatening illnesses, in the same patient presents a unique challenge. Guidelines …

Multidisciplinary pulmonary embolism response teams (PERTs) are being implemented to
improve care of patients with life-threatening PE. We sought to determine how the creation of …

Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States.
Although new therapeutic tools and strategies have recently been developed for the …

Background The impact of pulmonary embolism response teams (PERTs) on treatment
choice and outcomes of patients with acute pulmonary embolism (PE) is still uncertain …